目薬・潤滑剤市場レポート：タイプ別、用途別、地域別、2025-2033年

目薬・潤滑剤の市場の世界市場規模は2024年に213億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに315億米ドルに達し、2025～2033年の成長率（CAGR）は4.21％になると予測しています。眼疾患患者の増加、医薬品分野における研究開発（R&D）活動の活発化、ドライアイ症候群に関連するリスクを最小限に抑えるためのホルモン療法の人気の高まりなどが、市場を推進している主な要因です。

目薬・潤滑剤は、目の健康を維持・改善するために不可欠な製品です。様々な目の不快感の緩和、目の潤滑、目の健康全般の促進を目的として設計されています。人工涙液と血管収縮剤で構成されており、目の血管を収縮させることで充血を和らげます。特定の目の状態や症状に対応するために、さまざまな処方が用意されています。これらは、乾燥した環境、長時間のスクリーン使用、アレルギー、特定の病状などの要因によって引き起こされる乾燥、充血、かゆみ、炎症を防ぐために使用されます。

現在、目の症状を緩和し、不快感を和らげるための目薬・潤滑剤に対する需要の高まりが、市場の成長を後押ししています。これに加えて、目薬・潤滑剤を使用することの有益な側面や、適切なアイケアの必要性に関する意識の高まりが、市場の成長に寄与しています。さらに、ドライアイ症候群に関連するリスクを最小限に抑えるホルモン療法の人気が高まっていることも、良好な市場見通しをもたらしています。これとは別に、小売薬局を通じて提供される開放隅角緑内障治療薬の数が増加していることも、市場の成長を支えています。さらに、老年人口におけるさまざまな加齢に伴う眼障害の発生が増加していることも、市場の成長を後押ししています。さらに、安全性と有効性を向上させた革新的な点眼薬や潤滑剤を製造するために、技術的に高度な方法を採用するケースが増えていることも、市場の成長を後押ししています。

目薬・潤滑剤の市場傾向／促進要因：

眼疾患の増加

ドライアイ症候群、結膜炎、緑内障などの眼疾患の有病率の上昇は、目薬・潤滑剤の市場の主要な促進要因です。これとは別に、長時間のデジタル機器の使用、環境汚染、ライフスタイルの変化が、これらの疾患の発生率の増加に寄与しています。加えて、糖尿病、高血圧、肥満など、ライフスタイルの選択に関連して世界的に増加傾向にある疾患は、目の健康に影響を及ぼす可能性があります。例えば、糖尿病性網膜症は目に影響を及ぼす糖尿病の合併症です。さらに、急速な都市化と公害の増加が眼病の増加に寄与しています。大気汚染への暴露は、ドライアイ症候群やアレルギー性結膜炎などの症状に関連しています。様々な眼疾患の発生が増加しているため、これらの疾患に伴う不快感、かゆみ、充血、乾燥感を緩和する目薬・潤滑剤の需要が世界中で高まっています。

研究活動の増加

現在、加齢、ライフスタイルの変化、環境要因による眼疾患の有病率の増加により、効果的な目薬の開発が増加しています。また、テクノロジーの出現とそれに伴うスクリーン使用時間の増加により、眼精疲労や乾燥に悩まされる人が増えており、革新的なソリューションへの需要が高まっています。さらに、消費者の期待や要求が進化しているため、研究者は即座に緩和をもたらし、目の不快感の根本的な原因に対処する新しい製剤を求めるようになっています。従来の目薬は一時的な緩和をもたらすことが多く、頻繁に点眼する必要があるが、乾燥の根本原因に十分に対処できず、うるおいが長続きしないです。そのため、持続的な潤滑を提供し、自然な涙液膜を効果的に回復させ、眼の快適さと健康を促進することができる高度な製剤に対するニーズが高まっており、研究開発者は効率的な点眼薬や潤滑剤の開発に取り組んでいます。

スマートフォンやタブレットの利用拡大

現在、スマートフォン、タブレット、ノートパソコンなど、さまざまなスマートデバイスの利用が増加しており、利用者の目に負担をかけ、個人におけるドライアイ疾患の発生率を高めています。その上、スマートフォンは高解像度のスクリーンを搭載しており、光スペクトルの他の色に比べて波長が短くエネルギーが高いブルーライトを放射しています。ブルーライトに過度にさらされると、コンピュータービジョン症候群とも呼ばれるデジタル眼精疲労を引き起こします。スマートフォンの常時使用は、しばしば画面を長時間凝視することを伴い、これらの症状を悪化させ、眼疾患の有病率上昇の一因となっています。さらに、スマートフォンの使いすぎは、さまざまな眼科合併症の発生や、さまざまな目薬・潤滑剤の使用の増加につながっています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の目薬・潤滑剤市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：タイプ別

• 抗生物質
  • 市場動向
  • 市場予測
• ホルモン剤
  • 市場動向
  • 市場予測
• 人工涙液
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第7章 市場内訳：用途別

• 眼疾患
  • 市場動向
  • 主要セグメント
    • ドライアイ
    • 緑内障
    • 結膜炎
    • 屈折異常
    • その他
  • 市場予測
• アイケア
  • 市場動向
  • 市場予測

第8章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ

第9章 促進要因・抑制要因・機会

• 概要
• 促進要因
• 抑制要因
• 機会

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第12章 価格分析

第13章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Akorn Operating Company LLC
  • Alcon
  • Allergan Plc（AbbVie Inc.）
  • Bausch & Lomb Incorporated
  • Bayer AG
  • Johnson & Johnson
  • Maya Biotech Private Limited
  • Prestige Consumer Healthcare Inc.
  • Rohto Pharmaceutical Co. Ltd.
  • Sager Pharma Kft
  • Similasan Corporation

List of Figures

• Figure 1: Global: Eye Drops and Lubricants Market: Major Drivers and Challenges
• Figure 2: Global: Eye Drops and Lubricants Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Eye Drops and Lubricants Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Eye Drops and Lubricants Market: Breakup by Type (in %), 2024
• Figure 5: Global: Eye Drops and Lubricants Market: Breakup by Application (in %), 2024
• Figure 6: Global: Eye Drops and Lubricants Market: Breakup by Region (in %), 2024
• Figure 7: Global: Eye Drops and Lubricants (Antibiotics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 8: Global: Eye Drops and Lubricants (Antibiotics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 9: Global: Eye Drops and Lubricants (Hormones) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Global: Eye Drops and Lubricants (Hormones) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Eye Drops and Lubricants (Artificial Tears) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Eye Drops and Lubricants (Artificial Tears) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Eye Drops and Lubricants (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Eye Drops and Lubricants (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Eye Drops and Lubricants (Eye Diseases) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Eye Drops and Lubricants (Eye Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Eye Drops and Lubricants (Eye Care) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Eye Drops and Lubricants (Eye Care) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: North America: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: North America: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: United States: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: United States: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Canada: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Canada: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Asia-Pacific: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Asia-Pacific: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: China: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: China: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: Japan: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: Japan: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: India: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: India: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: South Korea: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: South Korea: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Australia: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Australia: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: Indonesia: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: Indonesia: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: Others: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: Others: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: Europe: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: Europe: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: Germany: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: Germany: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: France: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: France: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: United Kingdom: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 48: United Kingdom: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 49: Italy: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 50: Italy: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 51: Spain: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 52: Spain: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 53: Russia: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: Russia: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: Others: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: Others: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: Latin America: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: Latin America: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: Brazil: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: Brazil: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: Mexico: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: Mexico: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 63: Others: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 64: Others: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 65: Middle East and Africa: Eye Drops and Lubricants Market: Sales Value (in Million USD), 2019 & 2024
• Figure 66: Middle East and Africa: Eye Drops and Lubricants Market: Breakup by Country (in %), 2024
• Figure 67: Middle East and Africa: Eye Drops and Lubricants Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 68: Global: Eye Drops and Lubricants Industry: Drivers, Restraints, and Opportunities
• Figure 69: Global: Eye Drops and Lubricants Industry: Value Chain Analysis
• Figure 70: Global: Eye Drops and Lubricants Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Eye Drops and Lubricants Market: Key Industry Highlights, 2024 & 2033
• Table 2: Global: Eye Drops and Lubricants Market Forecast: Breakup by Type (in Million USD), 2025-2033
• Table 3: Global: Eye Drops and Lubricants Market Forecast: Breakup by Application (in Million USD), 2025-2033
• Table 4: Global: Eye Drops and Lubricants Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 5: Global: Eye Drops and Lubricants Market: Competitive Structure
• Table 6: Global: Eye Drops and Lubricants Market: Key Players

The global eye drops and lubricants market size reached USD 21.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 31.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.21% during 2025-2033. The growing cases of eye disorders, rising research and development (R&D) activities in the pharmaceutical sector, and increasing popularity of hormone therapy to minimize the risks associated with dry eye syndrome are some of the major factors propelling the market.

Eye drops and lubricants are essential products used for maintaining and improving eye health. They are designed to provide relief from various eye discomforts, lubricate the eyes, and promote overall eye health. They consist of artificial tears and vasoconstrictors, which help to ease redness by constricting the blood vessels in the eyes. They are available in a variety of formulations to address specific eye conditions and symptoms. They are used to prevent dryness, redness, itchiness, and irritation caused by factors, such as dry environments, prolonged screen time, allergies, or certain medical conditions.

At present, the increasing demand for eye drops and lubricants to alleviate symptoms and provide relief from discomfort in the eyes is impelling the growth of the market. Besides this, the rising awareness about the beneficial aspects of using eye drops and lubricants and the necessity of taking proper eye care is contributing to the growth of the market. In addition, the growing popularity of hormone therapy to minimize the risks associated with dry eye syndrome is offering a favorable market outlook. Apart from this, the increasing number of open-angle glaucoma therapeutics provided via retail pharmacies is supporting the growth of the market. Additionally, the rising occurrence of various age-associated eye disorders in the geriatric population is propelling the growth of the market. Moreover, the increasing adoption of technologically advanced methods to manufacture innovative eye drops and lubricants with improved safety and efficacy is bolstering the growth of the market.

Eye Drops and Lubricants Market Trends/Drivers:

Rising cases of eye diseases

The rising prevalence of eye disorders, including dry eye syndrome, conjunctivitis, and glaucoma, is a key driver for the eye drops and lubricants market. Apart from this, prolonged digital device usage, environmental pollution, and changing lifestyles contribute to the growing incidence of these conditions. In addition, conditions like diabetes, hypertension, and obesity, which are linked to lifestyle choices and are on the rise globally, can affect eye health. For instance, diabetic retinopathy is a complication of diabetes that affects the eyes. Moreover, rapid urbanization and increased pollution are contributing to the increase in eye diseases. Exposure to air pollution is linked to conditions like dry eye syndrome and allergic conjunctivitis. As there is an increase in the occurrence of various eye disorders, the demand for eye drops and lubricants to provide relief from discomfort, itching, redness, and dryness associated with these disorders is rising around the world.

Increasing research-related activities

At present, there is an increase in the development of effective eye drops due to the growing prevalence of eye diseases caused by aging, lifestyle changes, and environmental factors. Besides this, with the advent of technology and the consequent increase in screen time, individuals are increasingly susceptible to eye strain and dryness, thereby driving the demand for innovative solutions. In addition, evolving expectations and demands of consumers are prompting researchers to seek novel formulations that provide instant relief and address the underlying causes of eye discomfort. Traditional eye drops often offer temporary relief, necessitating frequent application, and do not adequately address the root causes of dryness or provide long-lasting moisture. Consequently, the growing need for advanced formulations that can provide sustained lubrication and effectively restore the natural tear film to promote ocular comfort and health is encouraging researchers to develop efficient eye drops and lubricants.

Growing utilization of smartphones and tablets

At present, the increasing utilization of various smart devices, including smartphones, tablets, and laptops, is exerting stress on the eyes of users and raising the incidence of dry eye disease in individuals. Besides this, smartphones are equipped with high-resolution screens that emit blue light, which has a shorter wavelength and higher energy compared to other colors on the light spectrum. Excessive exposure to blue light leads to digital eye strain, also called computer vision syndrome. The constant use of smartphones, often accompanied by prolonged periods of staring at screens, exacerbates these symptoms, contributing to the rising prevalence of eye diseases. Furthermore, the excessive use of smartphones is leading to an increase in the occurrence of various eye complications and the use of various eye drops and lubricants.

Eye Drops and Lubricants Industry Segmentation:

Breakup by Type:

Antibiotics

Hormones

Artificial Tears

Others

Artificial tears dominate the market

Artificial tears are non-prescription, over-the-counter eye drops that are used to treat symptoms associated with dry eyes. They are designed to mimic the natural tears produced by our eyes and are a blend of water, salts, and polymers that enhance viscosity and lubrication. Artificial tears provide immediate symptoms associated with dry eye syndrome, such as burning, irritation, redness, and a sensation of having something in your eyes. Artificial tears also help maintain the health and integrity of the ocular surface. By providing a surrogate for the natural tear film, they ensure the eye remains well-hydrated and nourished, reducing the risk of damage to the cornea.

Breakup by Application:

Eye Diseases

Dry Eye

Glaucoma

Conjunctivitis

Refractive Errors

Others

Eye Care

Eye diseases hold the largest share in the market

Eye drops and lubricants are significant tools in the management and treatment of a multitude of ocular conditions. The way they help cure eye diseases is multifaceted, depending on the active ingredient in the drops and the nature of the disease. They provide symptomatic relief by mimicking the natural tear film and lubricating the ocular surface. They are also used to treat bacterial infections, such as conjunctivitis (pink eye) or corneal ulcers. These medications contain substances that inhibit the growth of bacteria or kill them outright. They function by interfering with the replication of viruses while limiting the spread of infection and speed up the healing process.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest eye drops and lubricant market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the rising occurrence of dry eye syndrome, glaucoma, age-related macular degeneration, and cataracts among the aging population. Besides this, the prolonged screen time causing digital eye strain and dry eyes among the masses is propelling the growth of the market.

Another contributing aspect is the rising occurrence of eye allergies caused by climate change and rising levels of pollution. In addition, the increasing advancement in eye care treatments is supporting the growth of the market.

Asia Pacific is estimated to expand further in this domain due to the rising utilization of smartphones and laptops to access the internet. In addition, the growing construction of eye hospitals offering efficient eyecare services is positively influencing the market.

Competitive Landscape:

Key market players are investing in research operations to innovate and improve their eye drops and lubricants. They are also focusing on developing advanced formulations, ingredients, and delivery systems to enhance the effectiveness and comfort of their products. Top companies are striving to expand their product portfolios by introducing new eye drops and lubricants that cater to different consumer needs. They are also offering specialized products for dry eye relief, allergy relief, redness reduction, contact lens lubrication, and other specific eye care concerns. Leading companies are collaborating with healthcare professionals, including ophthalmologists and optometrists, to gain insights into patient needs and develop products tailored to those needs.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Akorn Operating Company LLC

Alcon

Allergan Plc (AbbVie Inc.)

Bausch & Lomb Incorporated

Bayer AG

Johnson & Johnson

Maya Biotech Private Limited

Prestige Consumer Healthcare Inc.

Rohto Pharmaceutical Co. Ltd.

Sager Pharma Kft

Similasan Corporation

Key Questions Answered in This Report:

• How has the global eye drops and lubricants market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global eye drops and lubricants market?
• What is the impact of each driver, restraint, and opportunity on the global eye drops and lubricants market?
• What are the key regional markets?
• Which countries represent the most attractive eye drops and lubricants market?
• What is the breakup of the market based on the type?
• Which is the most attractive type in the eye drops and lubricants market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the eye drops and lubricants market?
• What is the competitive structure of the global eye drops and lubricants market?
• Who are the key players/companies in the global eye drops and lubricants market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Eye Drops and Lubricants Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Antibiotics
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Hormones
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Artificial Tears
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Application

• 7.1 Eye Diseases
  • 7.1.1 Market Trends
  • 7.1.2 Key Segments
    • 7.1.2.1 Dry Eye
    • 7.1.2.2 Glaucoma
    • 7.1.2.3 Conjunctivitis
    • 7.1.2.4 Refractive Errors
    • 7.1.2.5 Others
  • 7.1.3 Market Forecast
• 7.2 Eye Care
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

• 9.1 Overview
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Akorn Operating Company LLC
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 Alcon
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 Financials
  • 13.3.3 Allergan Plc (AbbVie Inc.)
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 SWOT Analysis
  • 13.3.4 Bausch & Lomb Incorporated
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
  • 13.3.5 Bayer AG
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
    • 13.3.5.4 SWOT Analysis
  • 13.3.6 Johnson & Johnson
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
    • 13.3.6.4 SWOT Analysis
  • 13.3.7 Maya Biotech Private Limited
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
  • 13.3.8 Prestige Consumer Healthcare Inc.
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
    • 13.3.8.4 SWOT Analysis
  • 13.3.9 Rohto Pharmaceutical Co. Ltd.
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
  • 13.3.10 Sager Pharma Kft
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
  • 13.3.11 Similasan Corporation
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.